Prenetics Global Limited — Form 20-F Summary
Business context and reporting period
This is a shell company report filed in connection with Prenetics Global Limited’s completion of its business combination with Artisan Acquisition Corp. on May 18, 2022. Prenetics became a wholly owned subsidiary of the Company, and the Class A ordinary shares and warrants began trading on Nasdaq under PRE and PRENW on that date.
The filing does not represent a regular annual report for a fiscal year. Audited Prenetics financial statements for the years ended December 31, 2021 and 2020, and the three-year period ended December 31, 2021, are incorporated by reference from the Form F-4. The filing states that the financial statements use IFRS as issued by the IASB.
Financial condition and capitalization
- Unaudited pro forma cash and cash equivalents as of December 31, 2021 were $169.893 million after giving effect to the business combination and related financing transactions.
- Unaudited pro forma total equity was $219.703 million, with total capitalization also reported at $219.703 million.
- Pro forma debt was reported as zero.
- Pro forma share premium was $404.858 million, while reserves were negative $185.081 million.
- The company had 101,265,483 Class A ordinary shares and 9,713,864 Class B ordinary shares outstanding as of May 18, 2022.
- There were 17,352,393 warrants outstanding, including 11,311,386 public warrants and 6,041,007 private warrants.
The filing text does not provide clear values for revenue, net profit or loss, operating cash flow, free cash flow, gross margin, operating margin, or net margin. Those items are contained in, or incorporated by reference from, the Form F-4 financial statements and management’s discussion and analysis.
Material changes versus the prior comparable period
- The principal change was the May 18, 2022 business combination, under which Artisan merged into a PubCo subsidiary and Prenetics became a wholly owned subsidiary of Prenetics Global Limited.
- PIPE commitments were increased to 7,740,000 Class A shares. Forward purchase commitments were amended to provide for 3,870,000 Class A shares to be purchased by each of two investors, as described in the filing.
- The filing reports no significant changes under Item 8.B after the business combination.
- The company’s dual-class structure gives Class B shares 20 votes per share, compared with one vote per Class A share. Danny Sheng Wu Yeung beneficially controlled 65.74% of voting power through 9,713,864 Class B shares.
Guidance, outlook, risks, contingencies, and unusual items
- No formal financial guidance or quantified outlook is provided in this filing.
- Forward-looking statements address expected benefits and synergies of the business combination, cost savings, growth, liquidity, future market conditions, and future financial performance, but the filing cautions that actual results may differ materially.
- Risk factors are incorporated by reference from Amendment No. 8 to the Form F-4; the text provided does not reproduce those risk factors in detail.
- Public warrants became exercisable on June 17, 2022 and expire on May 18, 2027, unless earlier redeemed or otherwise terminated under their terms. The stated exercise price is $11.50 per 1.29 Class A shares, subject to adjustment.
- Private warrants may be exercised for cash or on a cashless basis and were subject to transfer restrictions until June 17, 2022.
- Dividend payments are discretionary and depend on revenue, earnings, and financial condition. No dividend-paying agent had been identified.
- The filing notes that Prenetics is a foreign private issuer and therefore is not required to provide U.S.-style quarterly reporting or proxy statements.
Most important facts for investors to verify
- Review the Form F-4 financial statements and MD&A for revenue, profitability, cash flow, margins, working capital, and historical trends, which are not clearly presented in this shell company report.
- Confirm the final cash proceeds, redemption levels, transaction expenses, and post-closing liquidity against the audited and unaudited pro forma financial information.
- Assess dilution from 17,352,393 outstanding warrants, the dual-class share structure, and any equity incentive awards.
- Review the incorporated Form F-4 risk factors, including risks related to the business combination, operating markets, regulatory matters, intellectual property, and future financing needs.
- Verify ownership and voting concentration, including the Class B shares controlled by Danny Sheng Wu Yeung and the related governance implications.
- Review the terms and lock-up restrictions applicable to shares held by the sponsor, principal shareholders, and executives.